GILD vs REGN
GILD and REGN side by side — valuation & fundamentals (public data).
Key statistics
| Metric | GILDGILEAD SCIENCES, INC. | REGNREGENERON PHARMACEUTICALS, INC. |
|---|---|---|
| Market cap | $162.94B | — |
| P/E (TTM) | 17.9 | 16.0 |
| P/B | 6.93 | — |
| Revenue | $29.74B(TTM) | $14.92B(TTM) |
| Net income | $9.22B(TTM) | $4.42B(TTM) |
| EPS, diluted | $7.35(TTM) | $40.96(TTM) |
Figures from SEC filings · for reference only · not investment advice
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)